Introduction
The clinical uses of radiological imaging invade almost all medical specialties and are frequently changing; to keep abreast with them is a constant challenge to investigators and clinicians. In the past decade a wide variety of sophisticated, costly, and potentially risky diagnostic procedures are becoming available, and at the present time we still do not know how to assess what is to be learned and how to examine selectively those imaging contributions of greatest significance and promise. In many instances, comparatively simple laboratory tests and radiographic procedures will adequately supplement the patient's history and physical examination and will supply the additional data required for diagnosis and effective management. We are nevertheless continuing to investigate and develop the potential of a host of new static and dynamic imaging technologies such as computed tomography and fluoroscopy, positron emission tomography, heavy ion radiography, nuclear magnetic resonance, microwave imaging, fluorescent-excitation imaging, and many more in addition to new developments in radiography, nuclear medicine, ultrasonography, and thermography. All these, and more, are designed to achieve two important goals: to improve medical diagnosis and to decrease the radiation dose.
These new imaging technologies promise potential benefits, but are not without potential risk. The introduction of ionizing radiations in medical imaging has brought with it concomitant health hazards of low-dose radiation exposure. During the present discussion, I should like to share what we know, and what we do not know of these health hazards of lowlevel radiation and why the estimates of these hazards continue to be clouded by scientific dispute and controversy. I shall use as my setting the scientific evidence--epidemiological studies and laboratory animal experiments--for estimating numer- ical risk coefficients for health hazards to human populations exposed to low-level radiation. I shall try to present, however briefly, the areas of agreement and disagreement among radiation scientists as to the health effects of very low levels of radiation, even levels as low as our natural background, and particularly levels to be expected in diagnostic medical imaging.
What are the Biological Effects of Low-Level Radiation?
My remarks will be resticted primarily to those so-called delayed or late health effects in humans following exposure to low-LET x-rays and gamma rays from radioactive sources, since these are the ionizing radiations most often encountered in diagnostic radiological medicine and in nuclear industries. Briefly, low-level ionizing radiation can affect the cells and tissues of the body in three important ways. First, if the macromolecular lesion occurs in one or a few cells, such as those of the hematopoietic tissues, the irradiated cell can occasionally transform into a cancer cell, and after a period of time there is an increased risk of cancer developing in the exposed individual. This effect is called carcinogenesis. Second, if the developing embryo or fetus is exposed during gestation, injury can occur to the proliferating and differentiating cells and tissues, leading to developmental abnormalities in the newborn. This effect is called teratogenesis. Third, if the injury is in the reproductive cell of the testis or ovary, the hereditary structure or genome of the cell can be altered, and the injury can be expressed in the descendants of the exposed individual. The effect is called mutagenesis or a genetic effect.
There are a number of other possible biological effects of ionizing radiations, such as cataracts of the lens of the eye, or impairment of fertility, but these three important effects--carcinogenic, teratogenic and genetic--are of greatest concern. This is because a considerable amount of scientific information is known from epidemiological studies of exposed human populations and from laboratory animal experiments. Most scientists believe that any exposure to radiation, even possibly at very low levels of dose, carries some risk of such deleterious effects. Furthermore, as the dose of radiation increases above very low levels, the risk of these deleterious effects increases in the exposed populations. It is these latter observations that have been central to public concern about the possible health effects of low-level radiation, and to the task of determining risk estimates for establishing standards for protecting the health of exposed human populations. The epidemiological data on exposed human populations are still highly uncertain in regard to the forms of the dose-response relationships for radiation-induced cancer, and this is especially the case for low dose levels. Therefore, it has been necessary to estimate human cancer risk at low doses primarily from observations at relatively high doses. To do this, various forms of no-threshold linearquadratic dose-response relationships are now most frequently used, recognizing the lack of our scientific understanding of fundamental mechanisms of radiation-induced cancer in man. In considering the many forms of the dose-response relationships applied to the epidemiological data, it is not known whether the cancer incidence observed at high dose levels applies also at low levels.
As yet, there are no reliable methods for estimating the repair of injured cells and tissues of the body exposed to very low radiation doses and dose rates. And, further, there are no methods of identifying those persons who may be particularly susceptible to radiation injury.
From the epidemiological surveys of irradiated populations exposed in the past, there is only limited information on the precise radiation doses absorbed by the tissues and organs of the body. Furthermore, the complete cancer incidence in each population studied still is not known, since new cases of cancer continue to appear with the passing of time. Thus, any estimation of risks to health based on such limited dose-response information must be incomplete until the entire study population has died of natural causes.
Finally, little is known of the role of competing environmental and other host factors--biological, chemical or physical factors--existing at the time of radiation exposure, or following exposure, which may affect and influence the carcinogenic, teratogenic, or genetic effects of low-level radiation.
What are the Problems of the Dose-Response Relationships for Radiation-Induced Human Cancer
There is still great uncertainly in regard to the shapes of the dose-response curves for cancer induction in humans by radiation, and especially at low doses. Estimates of risk at low doses appear to depend more on what is assumed about the mathematical form of the dose-response function than on the epidemiological data themselves. Wherever possible, in estimating the cancer risk from low doses of low-LET radiation, current scientific opinion suggest the use of a linear-quadratic dose-response model that was felt to be consistent with epidemioloigical and radiobiological data in preference to more extreme dose-response models. In this regard, the current Review of a large number of the available doseincidence curves for cancer in irradiated populations has demonstrated that for different radiation-induced cancer, whether in man or in experimental animals, the extent of variation in the shapes of the curves does not permit determination of any of these parameter values with precision, or of assuming their values, or of assuming any fixed relationship between two or more of these parameters. In the case of the available epidemiological data on irradiated populations, this general dose-response mathematical form cannot be universally applied. It has become necessary to simplify the model by reducing the number of parameters or by eliminating those parameters which will have the least effect on the form of the curve in the dose range at low levels of radiation. Such simpler models with increasing complexity are the linear, quadratic, linear-quadratic, and finally, the linear-quadratic form with an exponential modifier due to the effect of cell-killing similar to the general from ( Figure 1 The estimate of the cancer hazard of low-level radiation is said to be clouded by scientific dispute. In particular, there appears to be strong disagreement among some scientists as to the effects of very low levels of radiation, even levels as low as our natural radiation background, and of diagnostic radiological exposure levels. Most scientists would generally agree that low-level radiation is that which fails within the dose range considered permissible for occupational exposure. There is, at present, only one set of standards for radiation exposure accepted throughout the world.10 According to these standards, 5 rem to the whole body per individual radiation worker per year would be the allowable upper limit of low-level radiation. In this context, most of the estimated delayed cancer deaths which may be associated with a so-called hypothetical nuclear reactor accident and with diagnostic radiological exposure levels are therefore considered by some scientists to be caused by exposures well below the occupational limits. If it is assumed that any extra radiation above natural background, however small, causes additional cancer, then if millions of people are exposed, some extra cancers will result. Other scientists strongly dispute this, and firmly believe that low-level radiation is nowhere near as dangerous as their adversarial colleagues would insist. Unfortunately, since the health effects, if any, are so rarely seen because the exposures are so small, the issue may never be resolved--it may be beyond the ability of science and mathematics to decipher. However, there is one standard--natural background radiation--with which to compare additional radiation exposure. At Three Mile Island, for example, the total radiation dose to the population was about 1 percent of natural background--a level where no health effects can be seen.
It is just this type of controversy that has been highlighted recently by some radiation scientists. It is a most difficult task to estimate the carcinogenic risk of low-dose low-LET whole body radiation. The quantitative estimation of the carcinogenic risk of low-dose, low-LET radiation is subject to numerous uncertainties. The greatest of these concerns the shape of the dose-response curve. Others include the length of the latent period, the RBE for fast neutrons and alpha radiation relative to gamma and x radiation, the period during which the radiation risk is expressed, the model used in projecting risk beyond the period of observaton, the effect of dose rate or dose fractionation, and the influence of differences in the natural incidence of specific types of cancer. In addition, uncertainties are introduced by the biological risk characteristics of humans, e.g., the effect of age at irradiation, the influence of any disease for which the radiation was given therapeutically, and the influence of length of observation or follow-up. The collective influence of these uncertainties is such as to deny great credibility to any estimates of human cancer risk that can be made for low-dose, low-LET radiation. The three exposure situations do not reflect any circumstances that would normally occur, but embrace the areas of concern--general population and occupational exposure and single and continuous exposure.
Below these dose levels chosen for the current report, the uncertainties of extrapolation of risk to very low levels were considered to be too great to justify risk estimation. The selected annual exposure, although only one-fifth the maximal permissible dose for occupational exposure, is nevertheless consistent with occupational exposures in the medical and nuclear industries. The U.S. 1969-1971 life-table was used as the basis for the calculations, and all results are expressed in terms of excess cancers per million persons throughout their lifetime after exposure. The expression time was taken as 25 years for leukemia and the remaining years of life for other cancers. Separate estimates were made for cancer mortality and cancer incidence.
The resulting cancer mortality risk estimates calculated for all forms of cancer differ by as much as an order of magnitude. The uncertainty derives chiefly from the range of dose-response models used, from the alternative absolute and relative projection models, and from the sampling variation in the source data. The lowest estimates are derived from the pure quadratic model; the highest, from the linear model. The linear-quadratic model provides estimates intermediate between these two extremes.
In the absence of any increased radiation exposure, among one million persons of life-table age and sex composition in the United States, about 164,000 persons would be expected to die from cancer, according to present cancer mortality rates. For a situation in which these one million persons are exposed to a single dose increment of 10 rads of low-LET radiation, the linear-quadratic model
For continuous lifetime exposure to 1 rad per year, the increase in cancer mortality, according to the linear-quadratic model, ranges from about 3 percent to 8 percent over the normal expectation, depending on the projection model.
Cancer-incidence risk estimates are less firm than mortality estimates; a variety of dose-response models and several data sources are used. The doseresponse models produce estimates that differ by more than an order of magnitude, whereas the different data sources give broadly similar results. For the linear-quadratic model and for continuous lifetime exposure to 1 rad per year, for example, the increased risks expressed as percent of the normal incidence of cancer in males are about 2 percent to 6 percent, depending on the projection model. Risks for females are substantially higher than those for males, due primarily to the relative importance of radiation-induced thyroid and breast cancer. I believe that the potential health hazards of low-level radiation are central to the development of new imaging technologies in medicine. I believe that a substantial part of the controversy of government regulation and control has been mounted on the question of low-level radiation and linked to public acceptance of rigid and inflexible radiation protection standards in matters of radiation and health. In a third of a century of inquiry, embodying among the most extensive and comprehensive scientific efforts on the health effects of an environmental agent, certain practical information necessary for determination of radiation protection standards for public health policy is still lacking, and may remain so. It is now assumed that exposure to radiation at low levels of dose carries some risk of deleterious effects. However, how low this level may be, or the probability, or magnitude of the risk, still are not known. Our best scientific knowledge and our best scientific advice are essential for the protection of the public health, and for the effective application of new technologies in medicine and industry. Man cannot dispense with those activities which inevitably involve exposure to low levels of ionizing radiation in medicine, where he readily recognizes some degree of risk to health, however small, exists. In the evaluation of such risks from radiation in medicine, it is also necessary to limit the radiation exposure to a level at which the risk is acceptable both to the individual and to society.
